Sinossi
CYTOTOXIC T LYMPHOCYTES-INDUCTION AND ACTIVATION ...124 EPSTEIN BARR VIRUS ASSOCIATED TUMOURS ...125 Immunoblastic lymphomas ...126 Burkitt's lymphoma ...127 NPC and Hodgkin's lymphoma ...127 Vaccines for EBV associated malignancies ...128 HUMAN PAPILLOMA VIRUS (HPV) ASSOCIATED TUMOURS ...129 T cell responses against HPV ...130 Cytotoxic T cell responses in HPV infection ...130 Vaccines and clinical trials ...132 Recombinant viral vaccines ...132 Peptide vaccines ...133 Bacterial fusion protein vaccines ...134 Potential Pitfalls for CTL based immunotherapy of CaCX ...134 PROSPECTS FOR OTHER VIRALL Y ASSOCIATED CANCERS ...135 Hepatitis viruses and primary liver cancer ...135 Human herpes virus 8 and Kaposi's sarcoma ...136 Human T lymphotropic virus and adult T cell leukaemia ...136 Emerging tumour viruses ...137 CONCLUDING REMARKS ...137 ACKNOWLEDGEMENTS ...138 REFERENCES ...139 Chapter 8 ...147 The immune response to oncogenic fusion proteins LORENA PASSONI & CARLO GAMBACORTI-PASSERINI xiii INTRODUCTION ...147 BCRlABL ...149 CML immunotherapy ...150 Specific recognition of the bcr/abl protein ...150 CML vaccination ...152 FUSION PROTEINS AND TUMOUR ESCAPE ...1 52 CONCLUDING REMARKS ...154 REFERENCES ...154 Chapter 9 ...157 Immunological significance ofhsp70 in tumor rejection ANTOINE MENORET INTRODUCTION ...157 PROGRESSOR AND REGRESSOR TUMORS ...157 CO-SEGREGATION OF EXPRESSION OF THE INDUCIBLE HSP70, BUT NOT OF THE CONSTITUTIVE HSC70, WITH A REGRESSIVE PHENOTYPE ...159 IMMUNIZATION WITH TUMOR-DERIVED HEAT SHOCK PROTEIN OF 70 KDA (HSP70IHSC70), NA TURALL Y OR ARTIFICIALLY COMPLEXED WITH ANTIGENIC PEPTIDES ...161 DIFFERENCE OF PEPTIDE BINDING DOMAINS BETWEEN THE INDUCIBLE HSP70 AND CONSTITUTIVE HSC70 ...163 XIV IMPLICATION FOR IMMUNOTHERAPY OF CANCER AND BEYOND ...165 ACKNOWLEDGMENTS ...166 REFERENCES ...166 Chapter 10 ...
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Contenuti
Contributers. 1. Immunogenicity of tumour associated antigens; S. Mian, et al. 2. Recognition of human tumours: cancer/testis antigens; A.F. Kirkin, et al. 3. Recognition of human tumors: SEREX expression cloning to identify tumour antigens; U. Sahin, et al. 4. Recognition of human tumours: melanoma differentiation antigens; J. Zeuthen, A.F. Kirkin. 5. Carcinoembryonic Antigen as a Vaccine Target; J. Schlom, et al. 6. MUC1 mucin as a target for immunotherapy of cancer: Muc1 based immunotherapeutic strategies; M. Soares, O.J. Finn. 7. Recognition of human tumours: viral antigens as immunological targets for cytotoxic T Cells; S. Man. 8. The immune response to oncogenic fusion proteins; L. Passoni, C. Gambacorti-Passerini. 9. Immunological significance of hsp70 in tumor rejection; A. Ménoret. 10. Anti-idiotypic vaccination; L.G. Durrant, et al. 11. Genetically modified tumour cells for cancer immunization; S. Todryk, et al. 12. Antibody targeted therapy; delivery of radionuclides, toxins and drugs; A. Murray, et al. 13. Escape mechanisms in tumour immunity; G. Pawelec. Index.
Product Description
Book by None
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Altre edizioni note dello stesso titolo
Risultati della ricerca per Cancer Immunology: 30
Foto dell'editore
Cancer Immunology
Da: Books Puddle, New York, NY, U.S.A.
Valutazione del venditore 4 su 5 stelle
Condizione: New. pp. 280. Codice articolo 26295897
Compra nuovo
EUR 79,67
Spedizione EUR 3,42
Spedito in U.S.A.
Spedito in U.S.A.
Quantità: 1 disponibili
Foto dell'editore
Cancer Immunology
Da: Majestic Books, Hounslow, Regno Unito
Valutazione del venditore 4 su 5 stelle
Condizione: New. pp. 280 Illus. Codice articolo 7552006
Compra nuovo
EUR 77,56
Spedizione EUR 7,50
Spedito da Regno Unito a U.S.A.
Spedito da Regno Unito a U.S.A.
Quantità: 1 disponibili
Foto dell'editore
Cancer Immunology
Da: Biblios, Frankfurt am main, HESSE, Germania
Valutazione del venditore 4 su 5 stelle
Condizione: New. pp. 280. Codice articolo 18295891
Compra nuovo
EUR 78,91
Spedizione EUR 9,95
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 1 disponibili
Foto dell'editore
Cancer Immunology (immunology And Medicine, Volume 30)
Da: Basi6 International, Irving, TX, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Codice articolo ABEOCT25-118145
Compra nuovo
EUR 127,94
Spedizione gratuita
Spedito in U.S.A.
Spedito in U.S.A.
Quantità: 1 disponibili
Foto dell'editore
Cancer Immunology (immunology And Medicine, Volume 30)
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Codice articolo ABBB-163512
Compra nuovo
EUR 127,94
Spedizione gratuita
Spedito in U.S.A.
Spedito in U.S.A.
Quantità: 1 disponibili
Foto dell'editore
Cancer Immunology (Immunology and Medicine, Volume 30)
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
Condizione: New. In. Codice articolo ria9780792370079_new
Compra nuovo
EUR 163,87
Spedizione EUR 13,83
Spedito da Regno Unito a U.S.A.
Spedito da Regno Unito a U.S.A.
Quantità: Più di 20 disponibili
Immagini fornite dal venditore
Cancer Immunology
Editore:
Springer, Springer Mai 2001, 2001
ISBN 10: 0792370074
ISBN 13: 9780792370079
Nuovo
Rilegato
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Valutazione del venditore 5 su 5 stelle
Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -CYTOTOXIC T LYMPHOCYTES-INDUCTION AND ACTIVATION . . . . . . . . . . . . . . . . . . 124 EPSTEIN BARR VIRUS ASSOCIATED TUMOURS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125 Immunoblastic lymphomas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126 Burkitt's lymphoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127 NPC and Hodgkin's lymphoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127 Vaccines for EBV associated malignancies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128 HUMAN PAPILLOMA VIRUS (HPV) ASSOCIATED TUMOURS . . . . . . . . . . . . . . . . . . . . . . . . . 129 T cell responses against HPV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130 Cytotoxic T cell responses in HPV infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130 Vaccines and clinical trials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132 Recombinant viral vaccines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132 Peptide vaccines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133 Bacterial fusion protein vaccines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134 Potential Pitfalls for CTL based immunotherapy of CaCX . . . . . . . . . . . . . 134 PROSPECTS FOR OTHER VIRALL Y ASSOCIATED CANCERS . . . . . . . . . . . . . . . . . . . . . . . . . 135 Hepatitis viruses and primary liver cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135 Human herpes virus 8 and Kaposi's sarcoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136 Human T lymphotropic virus and adult T cell leukaemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136 Emerging tumour viruses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137 CONCLUDING REMARKS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137 ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138 REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139 Chapter 8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147 The immune response to oncogenic fusion proteins LORENA PASSONI & CARLO GAMBACORTI-PASSERINI xiii INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147 BCRlABL . . . 280 pp. Englisch. Codice articolo 9780792370079
Compra nuovo
EUR 160,49
Spedizione EUR 23,00
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 2 disponibili
Immagini fornite dal venditore
Cancer Immunology
Print on DemandDa: moluna, Greven, Germania
Valutazione del venditore 5 su 5 stelle
Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Contributers. 1. Immunogenicity of tumour associated antigens S. Mian, et al. 2. Recognition of human tumours: cancer/testis antigens A.F. Kirkin, et al. 3. Recognition of human tumors: SEREX expression cloning to identify tumour antigens U. Sahin, e. Codice articolo 5969851
Compra nuovo
EUR 136,16
Spedizione EUR 48,99
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: Più di 20 disponibili
Immagini fornite dal venditore
Cancer Immunology
Print on DemandDa: preigu, Osnabrück, Germania
Valutazione del venditore 5 su 5 stelle
Buch. Condizione: Neu. Cancer Immunology | R. A. Robins (u. a.) | Buch | xxi | Englisch | 2001 | Springer | EAN 9780792370079 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. Codice articolo 102549773
Compra nuovo
EUR 141,20
Spedizione EUR 70,00
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 5 disponibili
Foto dell'editore
Cancer Immunology
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Valutazione del venditore 5 su 5 stelle
Condizione: New. Provides a comprehensive account of the known groups of human tumour antigens, and the immune effector cells involved in tumour rejection. This book includes chapters that deals with various major groups of human tumour antigens are included, covering differentiation antigens, testes-associated antigens, CEA, mucin, and viral antigens. Editor(s): Robins, R. Adrian; Rees, R. C. Series: Immunology and Medicine. Num Pages: 253 pages, biography. BIC Classification: MJCL; MJCM. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 243 x 165 x 22. Weight in Grams: 558. . 2001. Hardback. . . . . Codice articolo V9780792370079
Compra nuovo
EUR 201,08
Spedizione EUR 10,50
Spedito da Irlanda a U.S.A.
Spedito da Irlanda a U.S.A.
Quantità: 15 disponibili